Choong-wae wins in finasteride patent dispute

Choong-wae Pharm won in an injunction trial sought by MSD Korea, which stops Choong-wae from manufacturing Finastartablet (finasteride) for the treatment of benign prostate hyperplasia (BPH), which was launched in the latter half of last year.

MSD Korea has initiated legal action against Choong-wae commercializing generic version of its BPH drug Proscar since the end of October, 2003. The su...